Manolova, Yana; Deneva, Vera; Antonov, Liudmil; at al (2014). “The effect of the water on the curcumin tautomerism: A quantitative approach”. Spectrochimica Acta132A (1): 815–820. doi:10.1016/j.saa.2014.05.096.
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997). “Stability of curcumin in buffer solutions and characterization of its degradation products”. J. Pharm. Biomed. Anal.15 (12): 1867-1876. doi:10.1016/S0731-7085(96)02024-9. PMID9278892.
Schmitt, B.; Holscher, D.; Schneider, B. (2000). “Variability of phenylpropanoid precursors in the biosynthesis of phenylphenalenones in Anigozanthos preissii”. Phytochemistry53 (3): 331–337. doi:10.1016/S0031-9422(99)00544-0. PMID10703053.
Gehlert, R.; Schoeppner, A.; Kindl, H. (1990). “Stilbene synthase from seedlings of Pinus sylvestris: purification and induction in response to fungal infection”. Molecular Plant-Microbe Interactions3: 444–449. doi:10.1094/MPMI-3-444.
Katsuyama, Y.; Kita, T.; Horinouchi, S. (2009). “Identification and characterization of multiple curcumin synthases from the herb Curcuma longa”. FEBS Lett.583 (17): 2799-2803. doi:10.1016/j.febslet.2009.07.029. PMID19622354.
Aggarwal BB, Shishodia S (2004). “Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning”. Ann. N. Y. Acad. Sci.1030: 434-441. doi:10.1196/annals.1329.054. PMID15659827.
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005). “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo”. J. Biol. Chem.280 (7): 5892-5901. doi:10.1074/jbc.M404751200. PMID15590663.
Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006). “Curry consumption and cognitive function in the elderly”. Am. J. Epidemiol.164 (9): 898-906. doi:10.1093/aje/kwj267. PMID16870699.
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers”. Planta Med.64 (4): 353-356. doi:10.1055/s-2006-957450. PMID9619120.
Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ (2007). “Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine”. Cancer Chemother. Pharmacol.60 (2): 171–177. doi:10.1007/s00280-006-0355-x. PMID17051370.
Yu, Hailong; Huang, Qingrong (2010). “Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch”. Food Chemistry119: 669-674. doi:10.1016/j.foodchem.2009.07.018.
Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T (2011). “Innovative preparation of curcumin for improved oral bioavailability”. Biol. Pharm. Bull.34 (5): 660-665. doi:10.1248/bpb.34.660. PMID21532153.
Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ (February 2018). “Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis”. Br J Sports Med52 (3): 167–175. doi:10.1136/bjsports-2016-097333. PMID29018060.
“Curcumin protects against cytotoxic and inflammatory effects of quartz particles but causes oxidative DNA damage in a rat lung epithelial cell line”. Toxicology and applied pharmacology227 (1). (2008). doi:10.1016/j.taap.2007.10.002. PMID18001810.
Iwata K, Iwasa M, Hara N, Matsumoto A, Kobayashi Y, Watanabe S, Adachi Y, Kaito M (2006). “Iron content and consumption of health foods by patients with chronic hepatitis C”. J. Gastroenterol.41 (9): 919-920. doi:10.1007/s00535-006-1860-8. PMID17048058.
Kawanishi, S. Oikawa, S. Murata, M. (2005). “Evaluation for safety of antioxidant chemopreventive agents”. Antioxid. Redox Signal.7 (11-12): 1728-1739. doi:10.1089/ars.2005.7.1728. PMID16356133.
Moos PJ, Edes K, Mullally JE, Fitzpatrick FA (2004). “Curcumin impairs tumor suppressor p53 function in colon cancer cells”. Carcinogenesis25 (9): 1611-1617. doi:10.1093/carcin/bgh163. PMID15090465.
espacenet.com
worldwide.espacenet.com
EP 20060004820, Giori, Andrea (Viale Ortles, 12, 20139 Milano, IT), Franceschi, Federico (Viale Ortles, 12, 20139 Milano, IT), published 2007-09-26, assigned to INDENA S.p.A. (Viale Ortles, 12, 20139 Milano, IT)
Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK (1997). “Stability of curcumin in buffer solutions and characterization of its degradation products”. J. Pharm. Biomed. Anal.15 (12): 1867-1876. doi:10.1016/S0731-7085(96)02024-9. PMID9278892.
Schmitt, B.; Holscher, D.; Schneider, B. (2000). “Variability of phenylpropanoid precursors in the biosynthesis of phenylphenalenones in Anigozanthos preissii”. Phytochemistry53 (3): 331–337. doi:10.1016/S0031-9422(99)00544-0. PMID10703053.
Kita, T.; Imai, S.; Sawada, H.; Kumagai, H.; Seto, H. (2008). “The biosynthetic pathway of curcuminoid in turmeric (Curcuma longa) as revealed by 13C-labeled precursors”. Biosci. Biotechnol. Biochem.72: 1789–1798. PMID18603793.
Katsuyama, Y.; Kita, T.; Horinouchi, S. (2009). “Identification and characterization of multiple curcumin synthases from the herb Curcuma longa”. FEBS Lett.583 (17): 2799-2803. doi:10.1016/j.febslet.2009.07.029. PMID19622354.
Srivastava KC, Bordia A, Verma SK (1995). “Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets”. Prostaglandins Leukot. Essent. Fatty Acids52 (4): 223-227. PMID7784468.
Aggarwal BB, Shishodia S (2004). “Suppression of the nuclear factor-κB activation pathway by spice-derived phytochemicals: reasoning for seasoning”. Ann. N. Y. Acad. Sci.1030: 434-441. doi:10.1196/annals.1329.054. PMID15659827.
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005). “Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo”. J. Biol. Chem.280 (7): 5892-5901. doi:10.1074/jbc.M404751200. PMID15590663.
Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH (2006). “Curry consumption and cognitive function in the elderly”. Am. J. Epidemiol.164 (9): 898-906. doi:10.1093/aje/kwj267. PMID16870699.
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS (1998). “Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers”. Planta Med.64 (4): 353-356. doi:10.1055/s-2006-957450. PMID9619120.
Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ (2007). “Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine”. Cancer Chemother. Pharmacol.60 (2): 171–177. doi:10.1007/s00280-006-0355-x. PMID17051370.
Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T (2011). “Innovative preparation of curcumin for improved oral bioavailability”. Biol. Pharm. Bull.34 (5): 660-665. doi:10.1248/bpb.34.660. PMID21532153.
Liu X, Machado GC, Eyles JP, Ravi V, Hunter DJ (February 2018). “Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis”. Br J Sports Med52 (3): 167–175. doi:10.1136/bjsports-2016-097333. PMID29018060.
Lal B, Kapoor AK, Asthana OP, Agrawal PK, Prasad R, Kumar P, Srimal RC (1999). “Efficacy of curcumin in the management of chronic anterior uveitis”. Phytother. Res.13 (4): 318-322. PMID10404539.
“Curcumin protects against cytotoxic and inflammatory effects of quartz particles but causes oxidative DNA damage in a rat lung epithelial cell line”. Toxicology and applied pharmacology227 (1). (2008). doi:10.1016/j.taap.2007.10.002. PMID18001810.
Iwata K, Iwasa M, Hara N, Matsumoto A, Kobayashi Y, Watanabe S, Adachi Y, Kaito M (2006). “Iron content and consumption of health foods by patients with chronic hepatitis C”. J. Gastroenterol.41 (9): 919-920. doi:10.1007/s00535-006-1860-8. PMID17048058.
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY (2001). “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions”. Anticancer Res.21 (4B): 2895-2900. PMID11712783.
Kawanishi, S. Oikawa, S. Murata, M. (2005). “Evaluation for safety of antioxidant chemopreventive agents”. Antioxid. Redox Signal.7 (11-12): 1728-1739. doi:10.1089/ars.2005.7.1728. PMID16356133.
Moos PJ, Edes K, Mullally JE, Fitzpatrick FA (2004). “Curcumin impairs tumor suppressor p53 function in colon cancer cells”. Carcinogenesis25 (9): 1611-1617. doi:10.1093/carcin/bgh163. PMID15090465.
